{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:30:06Z","timestamp":1793464206152,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40271-026-00827-0","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:41:01Z","timestamp":1784734861000},"page":"775-789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preferences for Parkinson\u2019s Disease Treatments: A Scoping Literature Review"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2099-9723","authenticated-orcid":false,"given":"Pablo","family":"Arija","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7346-2132","authenticated-orcid":false,"given":"Marco","family":"Boeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1467-4666","authenticated-orcid":false,"given":"Connie H.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"1","key":"827_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3(1):1\u201321.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"827_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41531-022-00410-y","volume":"8","author":"A Willis","year":"2022","unstructured":"Willis AW, Roberts E, Beck J, Fiske B, Ross W, Savica R, et al. Incidence of Parkinson disease in North America. NPJ Parkinsons Dis. 2022;8(1):170.","journal-title":"NPJ Parkinsons Dis"},{"issue":"10","key":"827_CR3","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","volume":"5","author":"G Deuschl","year":"2020","unstructured":"Deuschl G, Beghi E, Fazekas F, Varga T, Christoforidi KA, Sipido E, et al. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017. The Lancet Public Health. 2020;5(10):e551\u201367.","journal-title":"The Lancet Public Health."},{"issue":"10291","key":"827_CR4","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. The Lancet. 2021;397(10291):2284\u2013303.","journal-title":"The Lancet"},{"issue":"3","key":"827_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235\u201345.","journal-title":"Lancet Neurol"},{"key":"827_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","volume":"68","author":"AA Moustafa","year":"2016","unstructured":"Moustafa AA, Chakravarthy S, Phillips JR, Gupta A, Keri S, Polner B, et al. Motor symptoms in Parkinson\u2019s disease: A unified framework. Neurosci Biobehav Rev. 2016;68:727\u201340.","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"827_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrneurol.2012.126","volume":"8","author":"M Coelho","year":"2012","unstructured":"Coelho M, Ferreira JJ. Late-stage Parkinson disease. Nat Rev Neurol. 2012;8(8):435\u201342.","journal-title":"Nat Rev Neurol"},{"key":"827_CR8","volume-title":"Parkinson\u2019s disease: pathogenesis and clinical aspects","author":"I Zahoor","year":"2018","unstructured":"Zahoor I, Shafi A, Haq E. Pharmacological Treatment of Parkinson\u2019s Disease. In: Stoker TB, Greenland JC, editors. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects. Brisbane: Codon Publications; 2018."},{"key":"827_CR9","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.3233\/JPD-202104","volume":"10","author":"JM Dijk","year":"2020","unstructured":"Dijk JM, Espay AJ, Katzenschlager R, de Bie RMA. The choice between advanced therapies for Parkinson\u2019s disease patients: why, what, and when? J Parkinsons Dis. 2020;10:S65\u201373.","journal-title":"J Parkinsons Dis"},{"issue":"7","key":"827_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/jpm11070680","volume":"11","author":"V Metta","year":"2021","unstructured":"Metta V, Batzu L, Leta V, Trivedi D, Powdleska A, Mridula KR, et al. Parkinson\u2019s disease: Personalized pathway of care for device-aided therapies (DAT) and the role of continuous objective monitoring (COM) using wearable sensors. J Pers Med. 2021;11(7):680.","journal-title":"J Pers Med"},{"issue":"8","key":"827_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s40265-020-01310-2","volume":"80","author":"N Vijiaratnam","year":"2020","unstructured":"Vijiaratnam N, Foltynie T. Therapeutic strategies to treat or prevent off episodes in adults with Parkinson\u2019s disease. Drugs. 2020;80(8):775\u201396.","journal-title":"Drugs"},{"key":"827_CR12","doi-asserted-by":"crossref","unstructured":"Coelho M, Ferreira JJ. The Natural History of Parkinson\u2019s Disease. In: Falup-Pecurariu C, Ferreira J, Martinez-Martin P, Chaudhuri KR, editors.  Movement Disorders Curricula; 2017. p. 129\u201337.","DOI":"10.1007\/978-3-7091-1628-9_13"},{"issue":"1","key":"827_CR13","first-page":"55","volume":"2","author":"M Ryan","year":"2003","unstructured":"Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55\u201364.","journal-title":"Appl Health Econ Health Policy"},{"key":"827_CR14","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781107337855","volume-title":"Best-worst scaling: Theory, methods and applications","author":"JJ Louviere","year":"2015","unstructured":"Louviere JJ, Flynn TN, Marley AAJ. Best-worst scaling: Theory, methods and applications. Cambridge University Press; 2015."},{"key":"827_CR15","doi-asserted-by":"crossref","unstructured":"Louviere J, Hensher D, Swait J. Conjoint preference elicitation methods in the broader context of random utility theory preference elicitation methods. In: Conjoint measurement: Methods and applications. Springer; 2007. p. 331-70.","DOI":"10.1007\/978-3-540-24713-5_14"},{"key":"827_CR16","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372.","DOI":"10.1136\/bmj.n71"},{"key":"827_CR17","unstructured":"National Institute for Health and Care Excellence. The guidelines manual. Appendices B\u2013I NICE process and methods; 2012."},{"key":"827_CR18","volume-title":"Systematic reviews: CRD\u2019s guidance for undertaking reviews in healthcare","author":"Centre for Reviews and Dissemination","year":"2009","unstructured":"Centre for Reviews and Dissemination. Systematic reviews: CRD\u2019s guidance for undertaking reviews in healthcare. York: University of York NHS Centre for Reviews & Dissemination; 2009."},{"key":"827_CR19","unstructured":"EUnetHTA. Methodological Guidelines: Process of Information Retrieval for Systematic Reviews and Health Technology Assessments on Clinical Effectiveness. 2013."},{"issue":"1","key":"827_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332.","journal-title":"Int J Soc Res Methodol"},{"issue":"1","key":"827_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2288-13-48","volume":"13","author":"HM Daudt","year":"2013","unstructured":"Daudt HM, Van Mossel C, Scott SJ. Enhancing the scoping study methodology: a large, inter-professional team\u2019s experience with Arksey and O\u2019Malley\u2019s framework. BMC Med Res Methodol. 2013;13(1):48.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"827_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1748-5908-5-69","volume":"5","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O\u2019Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5(1):69.","journal-title":"Implement Sci"},{"key":"827_CR23","unstructured":"Thach A, Coulter J, Leach C, Sutphin J, Mansfield C. On-demand treatment preferences of patients with Parkinson's disease and \"Off\" episodes: heterogeneity across patient subgroups. In: Movement Disorders. Wiley:  2020. p. S427\u2013S8."},{"issue":"1","key":"827_CR24","doi-asserted-by":"publisher","first-page":"238146832097840","DOI":"10.1177\/2381468320978407","volume":"6","author":"B Hauber","year":"2021","unstructured":"Hauber B, Mange B, Zhou M, Chaudhuri S, Benz HL, Caldwell B, et al. Parkinson\u2019s patients\u2019 tolerance for risk and willingness to wait for potential benefits of novel neurostimulation devices: a patient-centered threshold technique study. MDM Policy Pract. 2021;6(1):2381468320978407.","journal-title":"MDM Policy Pract"},{"issue":"10","key":"827_CR25","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.jval.2017.06.001","volume":"20","author":"T Marshall","year":"2017","unstructured":"Marshall T, Pugh A, Fairchild A, Hass S. Patient preferences for device-aided treatments indicated for advanced Parkinson disease. Value Health. 2017;20(10):1383\u201393.","journal-title":"Value Health"},{"key":"827_CR26","doi-asserted-by":"crossref","unstructured":"Serbin M, Marras C, Mansfield C, Leach C, Yonan C, Sheehan M, et al. Patients\u2019 preferences for adjunctive Parkinson\u2019s disease treatments: a discrete-choice experiment. Patient Prefer Adher. 2023;17:2263\u201377.","DOI":"10.2147\/PPA.S420051"},{"key":"827_CR27","doi-asserted-by":"crossref","unstructured":"Thach A, Sutphin J, Coulter J, Leach C, Pappert E, Mansfield C. Patient preferences for treating \u201cOFF\u201d episodes in Parkinson\u2019s disease: a discrete choice experiment. Patient Prefer Adher. 2021; p. 1187\u201396.","DOI":"10.2147\/PPA.S301644"},{"key":"827_CR28","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s11136-015-1187-0","volume":"25","author":"C Kerr","year":"2016","unstructured":"Kerr C, Lloyd EJ, Kosmas CE, Smith HT, Cooper JA, Johnston K, et al. Health-related quality of life in Parkinson\u2019s: impact of \u2018off\u2019 time and stated treatment preferences. Qual Life Res. 2016;25:1505\u201315.","journal-title":"Qual Life Res"},{"issue":"7","key":"827_CR29","doi-asserted-by":"publisher","first-page":"A254","DOI":"10.1016\/j.jval.2011.08.130","volume":"14","author":"A Lloyd","year":"2011","unstructured":"Lloyd A, Herdman M, Gonzalez P. PMD59 Complicated Parkinson\u2019s disease: discrete choice analysis to assess patients\u2019 preferences. A pilot study. Value Health. 2011;14(7):A254\u20135.","journal-title":"Value Health"},{"issue":"8","key":"827_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160771","volume":"11","author":"MG Weernink","year":"2016","unstructured":"Weernink MG, van Til JA, van Vugt JP, Movig KL, Groothuis-Oudshoorn CG, Ijzerman MJ. Involving patients in weighting benefits and harms of treatment in Parkinson\u2019s disease. PLoS ONE. 2016;11(8):e0160771.","journal-title":"PLoS ONE"},{"key":"827_CR31","first-page":"763","volume":"10","author":"MG Weernink","year":"2017","unstructured":"Weernink MG, Van Til JA, Groothuis-Oudshoorn CG, Ijzerman MJ. Patient and public preferences for treatment attributes in Parkinson\u2019s disease. Patient-Patient-Cent Outcomes Res. 2017;10:763\u201372.","journal-title":"Patient-Patient-Cent Outcomes Res."},{"issue":"1","key":"827_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/03007995.2022.2129800","volume":"39","author":"S Fujioka","year":"2023","unstructured":"Fujioka S, Mishima T, Yamazaki T, Bebrysz M, Nomoto M, Yamaguchi J, et al. Neurologists\u2019 preferences for device-aided therapy for advanced Parkinson\u2019s disease in Japan. Curr Med Res Opin. 2023;39(1):91\u2013104.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"827_CR33","doi-asserted-by":"publisher","first-page":"9526138","DOI":"10.1155\/padi\/9526138","volume":"2025","author":"N Nishikawa","year":"2025","unstructured":"Nishikawa N, Kogo Y, Ishida T, Takahashi K, Takeda A. Patients\u2019 preferences for Parkinson\u2019s disease pharmacotherapy: an online discrete choice experiment. Parkinson\u2019s Dis. 2025;2025(1):9526138.","journal-title":"Parkinson\u2019s Dis"},{"issue":"1","key":"827_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12910-023-00966-1","volume":"24","author":"KS Bywall","year":"2023","unstructured":"Bywall KS, Drevin J, Groothuis-Oudshoorn C, Veldwijk J, Nyholm D, Widner H, et al. Patients accept therapy using embryonic stem cells for Parkinson\u2019s disease: a discrete choice experiment. BMC Med Ethics. 2023;24(1):83.","journal-title":"BMC Med Ethics"}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-026-00827-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-026-00827-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-026-00827-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:38:00Z","timestamp":1793461080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-026-00827-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1007\/s40271-026-00827-0","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All data included in this targeted literature review are derived exclusively from previously published, publicly available sources. No new data were generated, collected, or analyzed by the authors for this manuscript. The studies identified through the systematic search of PubMed and Embase are fully accessible to readers through the original publications, subject to the access policies of the respective journals and databases.","order":1,"name":"Ethics","label":"Data Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CHY and ZB are employees of AbbVie. PA and MB are employees of OPEN Health. All authors declare no other competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PA: Design, search planning and implementation, title\/abstract screening, full text screening, data extraction, interpretation of results, manuscript draft. MB: Design, interpretation of results, review of manuscript. CHY: Interpretation of results, review of manuscript. ZB: Interpretation of results, review of manuscript.","order":3,"name":"Ethics","label":"Authors' Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}